Cutler Group LP Arrowhead Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Jan 18, 2024	BUY	$21.2 - $31.03 $53,000 - $77,575	2,500 New	2,500 $14,000
Q3 2022 Oct 25, 2022	SELL	$29.63 - $48.31 $85,927 - $140,099	-2,900 Reduced 53.7%	2,500 $4,000
Q2 2022 Aug 04, 2022	BUY	$27.79 - $50.61 $150,066 - $273,294	5,400 New	5,400 $13,000
Q1 2022 Apr 14, 2022	SELL	$39.62 - $69.97 $3,961 - $6,997	-100 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$61.35 - $90.47 $177,915 - $262,363	-2,900 Reduced 96.67%	100 $4,000
Q1 2020 May 07, 2020	SELL	$20.56 - $63.12 $28,784 - $88,368	-1,400 Reduced 31.82%	3,000 $6,000
Q4 2019 Feb 06, 2020	BUY	$28.14 - $73.01 $123,816 - $321,244	4,400 New	4,400 $102,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.